We are live on
!
Find out more
SC
Savant Capital Portfolio holdings
AUM
$20.7B
1-Year Est. Return
19.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.14%
1 Year Est. Return
+19.76%
3 Year Est. Return
+51.75%
5 Year Est. Return
+48.44%
10 Year Est. Return
+194.21%
AUM
$282M
AUM Growth
+$18.5M
(+7%)
Cap. Flow
+$14M
Cap. Flow
% of AUM
4.94%
Top 10 Holdings %
Top 10 Hldgs %
50.1%
Holding
219
New
9
Increased
117
Reduced
61
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$8.6M |
| 2 |
Navient
NAVI
|
+$2.22M |
| 3 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$1.15M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$884K |
| 5 |
Regal Rexnord
RRX
|
+$780K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$2.33M |
| 2 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$1.18M |
| 3 |
AGN
Allergan Inc
AGN
|
+$587K |
| 4 |
GE Aerospace
GE
|
+$546K |
| 5 |
State Street SPDR S&P China ETF
GXC
|
+$456K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.48% |
| 2 | Financials | 7.38% |
| 3 | Industrials | 5.69% |
| 4 | Technology | 4.2% |
| 5 | Consumer Staples | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $37.6M | 13.31% |
777,939
+179,704
| +30% | +$8.6M |
|
|
2
State Street SPDR S&P China ETF
GXC
$442M
| $29M | 10.26% |
342,233
-5,627
| -2% | -$456K |
|
3
Vanguard Total Stock Market ETF
VTI
$658B
| $16M | 5.68% |
149,469
+6,677
| +5% | +$713K |
|
4
iShares Dow Jones US ETF
IYY
$2.94B
| $15.7M | 5.55% |
299,208
-3,592
| -1% | -$187K |
|
5
Vanguard Mega Cap Value ETF
MGV
$13.1B
| $11.1M | 3.92% |
185,112
+3,011
| +2% | +$181K |
|
6
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $10.9M | 3.85% |
273,136
+8,284
| +3% | +$325K |
|
7
iShares Core S&P 500 ETF
IVV
$881B
| $6.65M | 2.36% |
32,008
-1,425
| -4% | -$296K |
|
8
Vanguard Small-Cap Value ETF
VBR
$37.1B
| $5.36M | 1.9% |
48,972
+2,870
| +6% | +$305K |
|
9
Vanguard Value ETF
VTV
$186B
| $5.13M | 1.82% |
61,325
+3,017
| +5% | +$253K |
|
10
Apple
AAPL
$4.9T
| $4.13M | 1.46% |
132,848
-788
| -0.6% | -$23.8K |
|
11
ExxonMobil
XOM
$611B
| $3.76M | 1.33% |
44,269
+1,834
| +4% | +$163K |
|
12
Woodward
WWD
$23.4B
| $2.82M | 1% |
55,251
-365
| -0.7% | -$17.4K |
|
13
Vanguard Small-Cap ETF
VB
$79.7B
| $2.79M | 0.99% |
22,780
-2,393
| -10% | -$283K |
|
14
DexCom
DXCM
$29.6B
| $2.78M | 0.98% |
178,248
| – | – |
|
15
Wells Fargo
WFC
$265B
| $2.63M | 0.93% |
48,392
+257
| +0.5% | +$13.9K |
|
16
Schwab US Broad Market ETF
SCHB
$43B
| $2.57M | 0.91% |
305,754
+36,066
| +13% | +$302K |
|
17
AbbVie
ABBV
$450B
| $2.22M | 0.79% |
37,951
+126
| +0.3% | +$7.61K |
|
|
18
Navient
NAVI
$813M
| $2.2M | 0.78% |
+108,210
| New | +$2.22M |
|
19
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $2.2M | 0.78% |
53,818
+14,266
| +36% | +$580K |
|
20
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $2.15M | 0.76% |
10,402
+541
| +5% | +$112K |
|
21
Johnson & Johnson
JNJ
$609B
| $2.13M | 0.75% |
21,153
+1,701
| +9% | +$173K |
|
22
iShares MSCI EAFE Value ETF
EFV
$26B
| $2M | 0.71% |
37,443
-3,695
| -9% | -$194K |
|
23
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
| $1.98M | 0.7% |
40,599
+5,352
| +15% | +$257K |
|
24
RTX Corp
RTX
$261B
| $1.87M | 0.66% |
25,397
-291
| -1% | -$21.7K |
|
25
Pfizer
PFE
$143B
| $1.84M | 0.65% |
55,779
-602
| -1% | -$19.1K |
|
Similar funds
VARA
CB
ATO
MIC
SLAM
GT
EWA
Savant Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Savant Capital held 219 positions worth $282M, up 7% from $264M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Savant Capital deployed $14M of net new capital in Q1 2015, opening 9 new positions and adding to 117 existing holdings. Its largest new stake was Navient: 108,210 shares worth $2.2M.
By sector, the portfolio is most concentrated in Healthcare at 7.5% of assets, down from 7.8% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was WisdomTree Emerging Markets High Dividend Fund, an estimated $2.33M trimmed.
- Savant Capital's largest Q1 2015 buy was Navient: 108,210 shares worth $2.2M.
- Savant Capital added most to iShares Core MSCI Emerging Markets ETF in Q1 2015, an estimated $8.6M increase.
- Savant Capital's biggest Q1 2015 reduction was WisdomTree Emerging Markets High Dividend Fund, cutting an estimated $2.33M.
- Savant Capital fully exited Allergan Inc in Q1 2015, selling an estimated $587K.
- Savant Capital's ten largest holdings make up 50% of its $282M portfolio in Q1 2015.
- Savant Capital opened 9 new positions and closed 10 in Q1 2015.
- Savant Capital's portfolio value rose 7% quarter-over-quarter to $282M.
Based on Savant Capital's 13F filing for Q1 2015, filed 13 May 2015.